International Edition
Latest News
Health

Diabetes in Pregnancy & Epilepsy Risk in Babies: New Study

Maternal Diabetes and Epilepsy Risk in Offspring: A Growing Concern Recent research highlights a potential link between maternal diabetes – encompassing type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM) – and…

Diabetes in Pregnancy & Epilepsy Risk in Babies: New Study

Maternal Diabetes and Epilepsy Risk in Offspring: A Growing Concern

Recent research highlights a potential link between maternal diabetes – encompassing type 1 diabetes mellitus (T1DM), type 2 diabetes mellitus (T2DM), and gestational diabetes mellitus (GDM) – and an increased risk of epilepsy development in children. This emerging data underscores the importance of diligent health monitoring during pregnancy and post-delivery, particularly for mothers managing any form of diabetes.

The Link Between Maternal Diabetes and Childhood Epilepsy

While the overall risk remains relatively limited, studies are revealing a statistically significant association. Researchers emphasize the necessitate for early medical attention and preventative diagnosis to safeguard children’s health during their crucial developmental stages. A national cohort study of 2.3 million children in Sweden, following them from birth until epilepsy diagnosis (or until October 2023), revealed notable findings.

Study Findings: A Large-Scale Analysis

The Swedish study, conducted from 1998 to 2021, analyzed data from live-born children without major malformations. Of the 2,305,051 children studied, 14,283 (0.6%) were exposed to maternal T1DM, 3,833 (0.2%) to T2DM, and 36,388 (1.6%) to GDM. Over a median follow-up of 13 years, 17,800 (0.8%) cases of epilepsy were diagnosed. Children exposed to maternal diabetes demonstrated an increased risk of epilepsy across all subtypes, with type 1 and type 2 diabetes showing the most pronounced associations. [1]

Similar findings emerged from a study analyzing data from over two million children born in Ontario, Canada, between 2002 and 2018. This research indicated that approximately 7.6% of children were exposed to maternal diabetes, and over 10 years of follow-up, more than 17,800 cases of epilepsy were diagnosed. [4]

Potential Mechanisms and Contributing Factors

Researchers hypothesize that the association between maternal diabetes and epilepsy risk may be linked to several factors:

  • Pregnancy Complications: Increased incidence of complications such as premature birth, cesarean delivery, and preeclampsia.
  • Blood Sugar Fluctuations: Disturbances in maternal blood sugar levels during pregnancy.
  • Inflammation and Infection: Potential for increased inflammation and infections, impacting the child’s neurological development.

These factors can potentially disrupt the child’s early neurological development, increasing their susceptibility to epilepsy. [3]

Important Considerations and Future Research

It’s crucial to note that these studies do not establish a direct causal relationship between maternal diabetes and epilepsy. However, they strongly suggest a correlation and emphasize the necessity of close medical follow-up for children born to mothers with diabetes. Researchers are also investigating whether prenatal metabolic inflammatory exposures contribute to epilepsy development. [1]

Further research is needed to fully understand the underlying mechanisms and identify potential interventions to mitigate the risk. Analyzing paternal diabetes (type 1 and type 2) as a negative control exposure helps assess potential genetic confounding factors. [2]

Key Takeaways

  • Maternal diabetes (T1DM, T2DM, and GDM) is associated with a slightly increased risk of epilepsy in offspring.
  • The risk appears to be higher with type 1 and type 2 diabetes compared to gestational diabetes.
  • Close medical monitoring of children born to mothers with diabetes is crucial for early detection and intervention.
  • Further research is ongoing to determine the exact mechanisms linking maternal diabetes and epilepsy risk.
About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”